Emerging role of circulating tumor cells in cancer management.
作者信息
Mego Michal
机构信息
Department of Medical Oncology, Translational Research Unit, Comenius University, Faculty of Medicine and National Cancer Institute, Klenova 1, 833 10 Bratislava, Slovak Republic E-mail:
出版信息
Indian J Med Paediatr Oncol. 2014 Oct;35(4):237-8. doi: 10.4103/0971-5851.144962.
Abstract
摘要
相似文献
1
Emerging role of circulating tumor cells in cancer management.循环肿瘤细胞在癌症管理中的新兴作用。
Indian J Med Paediatr Oncol. 2014 Oct;35(4):237-8. doi: 10.4103/0971-5851.144962.
2
The emerging role of circulating tumor cells in cancer management.循环肿瘤细胞在癌症治疗中的新作用。
Am J Transl Res. 2020 Feb 15;12(2):332-342. eCollection 2020.
3
Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer.循环游离DNA或循环肿瘤DNA在卵巢癌和子宫内膜癌管理中的应用
Onco Targets Ther. 2019 Dec 27;12:11517-11530. doi: 10.2147/OTT.S227156. eCollection 2019.
4
The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.“液体活检”、循环肿瘤细胞及循环游离肿瘤DNA在肺癌诊断及耐药突变鉴定中的新兴作用
Curr Oncol Rep. 2017 Jan;19(1):1. doi: 10.1007/s11912-017-0564-y.
5
The emerging role of circulating tumor cell detection in genitourinary cancer.循环肿瘤细胞检测在泌尿生殖系统肿瘤中的新兴作用。
J Urol. 2012 Jul;188(1):21-6. doi: 10.1016/j.juro.2012.02.2558. Epub 2012 May 12.
6
Capturing Cancer: Emerging Microfluidic Technologies for the Capture and Characterization of Circulating Tumor Cells.捕捉癌症：新兴的微流控技术用于捕获和表征循环肿瘤细胞。
Small. 2015 Aug 26;11(32):3850-72. doi: 10.1002/smll.201403658. Epub 2015 May 20.
7
Liquid Biopsy for the Management of Patients with Colorectal Cancer.液体活检在结直肠癌患者管理中的应用。
Digestion. 2019;99(1):39-45. doi: 10.1159/000494411. Epub 2018 Dec 14.
8
Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA.乳腺癌中的血液生物标志物：从蛋白质到循环肿瘤细胞再到循环肿瘤DNA。
Tumour Biol. 2018 May;40(5):1010428318776169. doi: 10.1177/1010428318776169.
9
Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer.循环肿瘤DNA作为三阴性乳腺癌生物标志物的潜在管理
J Cancer. 2018 Nov 24;9(24):4627-4634. doi: 10.7150/jca.28458. eCollection 2018.
10
Circulating tumor cells as emerging tumor biomarkers in breast cancer.循环肿瘤细胞作为乳腺癌中新兴的肿瘤标志物。
Clin Chem Lab Med. 2011 Oct;49(10):1579-90. doi: 10.1515/CCLM.2011.628. Epub 2011 Jul 29.
引用本文的文献
1
Dielectric Characterization and Separation Optimization of Infiltrating Ductal Adenocarcinoma via Insulator-Dielectrophoresis.基于绝缘体介电泳的浸润性导管腺癌介电特性分析与分离优化
Micromachines (Basel). 2020 Mar 25;11(4):340. doi: 10.3390/mi11040340.
2
Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.循环肿瘤细胞的检测及其作为肝细胞癌诊断、预后和治疗监测生物标志物的意义。
Hepatology. 2021 Jan;73(1):422-436. doi: 10.1002/hep.31165. Epub 2021 Jan 18.
3
Technological advances in precision medicine and drug development.精准医学与药物研发中的技术进步。
Expert Rev Precis Med Drug Dev. 2016;1(3):331-343. doi: 10.1080/23808993.2016.1176527. Epub 2016 May 5.
本文引用的文献
1
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.AR-V7 与前列腺癌中对恩杂鲁胺和阿比特龙的耐药性。
N Engl J Med. 2014 Sep 11;371(11):1028-38. doi: 10.1056/NEJMoa1315815. Epub 2014 Sep 3.
2
Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?循环肿瘤细胞的生物标志物评估能否帮助指导转移性乳腺癌的治疗？
Cancers (Basel). 2014 Mar 25;6(2):684-707. doi: 10.3390/cancers6020684.
3
The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.开端的结束：循环肿瘤细胞作为去势抵抗性前列腺癌的生物标志物
J Clin Oncol. 2014 Apr 10;32(11):1104-6. doi: 10.1200/JCO.2013.54.7307. Epub 2014 Mar 10.
4
Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients.转移性乳腺癌患者循环肿瘤细胞中雌激素受体表达的异质性
PLoS One. 2013 Sep 18;8(9):e75038. doi: 10.1371/journal.pone.0075038. eCollection 2013.
5
HER2 discordance between primary and metastatic breast cancer: assessing the clinical impact.原发和转移性乳腺癌中 HER2 不一致：评估临床影响。
Cancer Treat Rev. 2013 Dec;39(8):947-57. doi: 10.1016/j.ctrv.2013.05.003. Epub 2013 Jun 10.
6
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.从乳腺癌患者的血液循环肿瘤细胞中鉴定出一种能够在异种移植模型中引发转移的细胞群体。
Nat Biotechnol. 2013 Jun;31(6):539-44. doi: 10.1038/nbt.2576. Epub 2013 Apr 21.
7
Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy.上皮-间充质转化诱导转录因子在原发性乳腺癌中的表达：新辅助治疗的影响。
Int J Cancer. 2012 Feb 15;130(4):808-16. doi: 10.1002/ijc.26037. Epub 2011 Apr 27.
8
Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis.原发性乳腺癌与转移癌中雌激素受体和 HER-2 受体的不一致性。
Oncologist. 2010;15(11):1164-8. doi: 10.1634/theoncologist.2010-0059. Epub 2010 Nov 1.
9
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells.检测不出循环肿瘤细胞的转移性乳腺癌患者的特征。
Int J Cancer. 2011 Jul 15;129(2):417-23. doi: 10.1002/ijc.25690. Epub 2010 Nov 28.
10
HER-2 gene amplification can be acquired as breast cancer progresses.随着乳腺癌的进展，HER-2基因扩增可能会出现。
Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9393-8. doi: 10.1073/pnas.0402993101. Epub 2004 Jun 11.
Zotero 插件